After century-long fight, US enacts health reforms. President Barack Obama has signed into law historic, sweeping reforms that lay out health care coverage for almost every American and realize the dreams of generations of past US leaders. Two fund houses have given their view about the impact of the event:
UOBAM 25th March 2010
Last Sunday, the US House of Representatives passed the US Health Care Reform Bill, and the response of the market was a broad rally in Healthcare stocks. The Healthcare sector had underperformed the wider market in 2009 because of the uncertainty over the reforms. The Reform Bill is more modest than what the market feared and the impact on the earnings of the healthcare sector is less than what the market has priced.
This removal of headline risk and the increase in clarity should benefit Healthcare stocks in the months ahead. Valuations of the Healthcare sector are at 20-year lows. The sector is also under- owned as uncertainty over the reforms has kept investors on the sidelines. We continue to be positive on the long term outlook for the Healthcare sector. The demand for Healthcare will continue to rise as the populations in the Developed Economies are ageing while those in the Emerging Markets are becoming more affluent. There are also still significant unmet needs in Healthcare and the truly innovative companies will continue to be rewarded.
Franklin Templeton 23rd March 2010
The legislation is designed to extend health care coverage to more than 32 million uninsured Americans—a market expansion that could potentially benefit drug companies, hospitals, medical devices companies and even insurers, though they may face challenges as the insurance business model changes.
The passage and signing of this bill into law marks the end of the legislative process, but only the beginning of the implementation and execution process, ultimately leading to coverage expansion of the uninsured starting in 2014. With clarity on the legislative front, we expect investors to revert back to evaluating the core fundamentals of the health care sector, where the strong secular growth opportunity may lead to potential outperformance. In general, we view the health care sector as a fertile area of investment due to demographics and innovation.





